EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Bioqual's enterprise value is $76.12 Mil.
Bioqual's Revenue for the trailing twelve months (TTM) ended in May. 2018 was $35.89 Mil. Therefore, Bioqual's EV-to-Revenue for today is 2.12.
The historical rank and industry rank for Bioqual's EV-to-Revenue or its related term are showing as below:
BIOQ's EV-to-Revenue is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 3.19 * Ranked among companies with meaningful EV-to-Revenue only.
As of today (2024-06-01), Bioqual's stock price is $72.50.
Bioqual's Revenue per Share for the trailing twelve months (TTM) ended in May. 2018 was $40.19. Therefore, Bioqual's PS Ratio for today is 1.80.
Bioqual EV-to-Revenue Historical Data
The historical data trend for Bioqual's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Bioqual's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bioqual's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Bioqual's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Bioqual's EV-to-Revenue falls into.
Bioqual's current Enterprise Value is $76.12 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Bioqual's Revenue for the trailing twelve months (TTM) ended in May. 2018 was $35.89 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bioqual's share price for today is $72.50.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in May. 2018 was $40.19.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bioqual EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Bioqual's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Bioqual Inc is a United States-based medical research company. It is engaged in providing contract research services focused on animal models of human diseases, including AIDS, influenza, RSV infection, flavivirus infections like Zika and Dengue, malaria, hepatitis, and cancer. The company is also involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. It provides services to the federal government, universities, and the life science and pharmaceutical industries. It derives revenue from the provision of contract research services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BIOQ has been successfully added to your 